Vol. 157, No. 2,1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 472-479
December 15,1988
THREE TYPES OF AMYLOID
PROTEIN
THEIR DIFFERENTIAL
PRECURSOR
EXPRESSION
mRNA IN HUMAN BRAIN:
IN ALZHEIMER'S
DISEASE
Seigo Tanaka I*, Shigenobu Nakamura I , Kunihiro Ueda 2, Masakuni Kameyama 3, Satoshi Shiojiri 4, Yasuyuki Takahashi 4, Nobuya Kitaguchi 4 and Hirataka Ito 4
IDepartment of Neurology and 2Department of Clinical Science and Laboratory Medicine, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan 3Department
of Neurology,
4Bio-Science
Sumitomo
Hospital,
Osaka
Laboratory, Life Science Research Asahi Chemical Industry Co. Ltd., Fuji-shi, Shizuoka 416, Japan
530, Japan
Laboratories,
Received October 12, 1988 Summary Three types of amyloid protein precursor (APP) mRNA, produced by alternative splicing, were detected by Northern blotting in human brains, b o t h c o n t r o l and A l z h e i m e r ' s disease. These mRNAs encode APP695 consisting of 695 amino acids, APP751 harboring a 56 amino acid insert homologous to a Kunitz-type trypsin inhibitor inside APP695, and APP770 containing an additional 19 amino acid insert. Another possible APP mRNA which encodes "APP714" containing a 19 amino acid insert was not found in brain samples tested. Quantitative analysis revealed that, although the relative expression levels of the three mRNAs were variable among individuals, there was no remarkable change in e x p r e s s i o n of A P P 6 9 5 and APP751 m R N A s in A l z h e i m e r ' s d i s e a s e c o m p a r e d w i t h control, but that A P P 7 7 0 m R N A level w a s e l e v a t e d significantly in Alzheimer's disease. © 1 9 8 8 A c a d e m i c P r e s s , Inc.
A
major
deposition
neuropathological
of
amyloid
vessels
(I-5).
protein
precursor
precursor from
the base
cell
surface
8-protein
Complementary
protein
finding
DNA
in
of A l z h e i m e r ' s
senile
(cDNA) clones
(APP) have been isolated (APP695),
sequence, receptors
*To whom correspondence
comprising has
with
a
structural large
472
encoding
and sequenced 695
amino
features
extracellular
should be addressed.
0006-291X/88 $1.50 Copyright © 1988 by Academic Press, Inc. All rights of reproduction in any form reserved.
plaques
acids
disease
and
is
cerebral
the amyloid (6-9).
This
as deduced
characteristic hydrophilic
of
domain
Vol. 157, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
and a m e m b r a n e - s p a n n i n g Recently,
hydrophobic region near the carboxyl terminus.
the core protein of heparan sulfate p r o t e o g l y c a n
to be h o m o l o g o u s
and a n t i g e n i c a l l y
indicative of their possible From
a
cDNA
library
isolated APP cDNA clones
related
to A P P
(10),
of
a
human
pAPP770),
together
apparently
identical to that previously
glioblastoma
cell
a cDNA clone
(11-13)
coding
region
leukocyte
and of
DNA
a 225-bp insert
pAPP695.
library
has
is
line,
we
(pAPP751
and
reported by others and APP770
(6-9).
of
that
genomic the
DNA
225-bp
The
have a 168-bp
(11), r e s p e c t i v e l y ,
Cloning revealed
species
(pAPP695) coding for a protein
new clones harboring the sequence for APP751 insert
which
identity.
(11), and found two new
with
was found
inside
from
insert
the
a human
in pAPP770
is d e r i v e d f r o m t w o exons, 1 6 8 - b p and 5 7 - b p long, that are s e p a r a t e d by an intron of about 3 kb long, exactly
to the
168-bp
insert
and that the f o r m e r
in p A P P 7 5 1 .
These
exon corresponds
two exons
and t h e i r
flanking ones are tentatively designated as H, I, J and K in the order of 5' to 3' d i r e c t i o n blot analysis,
(Fig. I).
the 2 2 5 - b p
haploid of h u m a n genome, are produced
As j u d g e d
insert
by
the r e s u l t of S o u t h e r n
(I-J) e x i s t s
as a s i n g l e
suggesting that the three species of APP m R N A
by alternative
splicing
(11).
It is of i n t e r e s t that the s e q u e n c e of 56 a m i n o I) encoded by exon I inhibitor activity
family to
transfected (11).
It
and/or
shows
(11-13).
trypsin
with pAPP770
seems
a close similarity
(Kunitz type)
inhibit
c o p y per
possible
in
compared that
APP770 might cause
In fact, the
with
inhibition
acids
(fragment
to
the basic trypsin
we
observed
lysate
COS-I
cells
pAPP695-transfected
cells
of
aberrant c a t a b o l i s m
of
a higher
protease(s) of
APP
by
and
APP751 lead to
a c c u m u l a t i o n of a m y l o i d 8-protein. In v i e w of the fact that the e x p r e s s i o n human
brains
blot analysis
has not b e e n s t u d i e d of APP m R N A s
in d e t a i l ,
obtained
473
of e x o n I and J in a d u l t we u n d e r t o o k
Northern
f r o m the b r a i n s of A l z h e i m e r ' s
Vol. 157, No. 2, 1 9 8 8 disease
patients
and
BIOCHEMICAL AND BIOPHYSICALRESEARCHCOMMUNICATIONS controls
using
site-specific
oligonucleotide
probes.
MATERIALS
AND METHODS
Postmortem b r a i n s w e r e o b t a i n e d f r o m n i n e A l z h e i m e r ' s diseas~ patients and eight a g e - m a t c h e d controls. Diagnosis was c o n f i r m e d b] histological examinations. The brains were r e m o v e d w i t h i n 3-10 hour~ after death, and kept frozen at - 7 0 ° C until use. Total cellular RNJ was prepared from frontal cortex (Brodmann areas 9 and 10) of eact b r a i n by the guanidium/CsCl method (14), a n d poly(A)+RNA wa~ isolated by oligo(dT)-cellulose chromatography (15). By criterion oI intactness of 8-actin mRNA, three samples of Alzheimer's d i s e a s e an6 four controls were selected for analysis of APP mRNAs. Northern blot analysis was performed using syntheti( oligonucleotide p r o b e s , A M - 1 1 , A M - 1 3 , A M - 1 4 a n d A M - 1 5 , d e s i g n e d t( differentiate four possible APP m R N A species (Fig. I) under the stringent h y b r i d i z a t i o n conditions e m p l o y e d (11). Glyoxal-denaturec poly(A)+RNA (4.0 p g per lane) was resolved by electrophoresis in 1.0~ agarose gel, and transferred to a Zeta Probe filter (Bio-Rad) (16) The filter was subjected to h y b r i d i z a t i o n w i t h one of the 32p-labellec o l i g o n u c l e o t i d e probes in 5 x SSC, containing 25 m M s o d i u m phosphat~ (pH 7.0), 5 x D e n h a r d t ' s s o l u t i o n , I% g l y c i n e , and 0.1% SDS at 55°( for 2 hours, and washed at 5 5 ° C in 6 x S S C c o n t a i n i n g 0.1% SD~
8om H I
8om HI
BglII
pAPP695
8"
pAPP695 /
pAPP751 l/
..-'~,ml A M - 1 1
.
!/ I~[,,AM-13 I I
k,
•
pAPP770 l/ -'"'-.
i I~ AM-14
(PAPP714) l/ AM-15
Iml ~
AM-14
Fiqure [. Schematic representations of APP cDNAs and synthetic oligonucleotide probes. The putative coding region of APP cDNA is shown by open boxes, and that of 8-protein by a solid box as marked by an arrowhead. I and J stand for inserts, and H and K for the adjacent exons (11). Four oligonucleotide probes and their hybridization sites (indicated by bars) are as follows: AM-11 (5'-CTGTTGTAGGAACTCGAACCACCT-3') for the H-K junction, AM-13 (5'-CTGTTGTAGGAATGGCGCTGCCAC-3') for the I-K junction, AM-14 (5'-CTGTTGTAGGAAGTTTAACAGGAT-3') for the J-K junction, AM-15 (5'-AAACTTTGGGACACTCGAACCACCTC-3') for the H-J junction.
474
Vol. 157, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(11). A f t e r a u t o r a d i o g r a p h y , the probe was washed out, and the f i l t e r r e u s e d for h y b r i d i z a t i o n w i t h a n o t h e r probe. D e n s i t o m e t r y of a u t o r a d i o g r a m s w a s c a r r i e d out w i t h J o o k o o P A N - 8 0 2 type d e n s i t o m e t e r .
RESULTS Hybridization AM-14,
revealed
mRNAs
(Fig.
2).
This
(6-9).
expression
level
groups,
APP751
mRNA
in the
human
was
among these
brain.
For density,
by
APP770
results
with
was
probe therefore,
and
type)
were
mRNA
and kb
reported in the
Alzheimer's
evidence
("APP714")
under
3.2-3.4
variation
control
(H-I-J-K
APP
AM-13
of A P P m R N A s
unequivocal
mRNA
possible
probe,
respective
those
both
presented
AM-15
of
AM-t1,
a considerable in
and A P P 7 7 0
with
that b o t h expressed
(H-J-K
type)
our conditions
used.
considered
represent
was
to
The
mRNA.
a quantitative i.e.
there
probes,
presence
coincided
Another
AM-14
the
individuals
(H-I-K type)
given
entirely
size
Although
not detectable
bands
three o l i g o n u c l e o t i d e
specifically
previously
disease
with
AND DISCUSSION
the
comparison
ratio
of
the
1
of e x p r e s s i o n
density
2
3
4
of
5
6
levels,
APP
7
band
the relative to
that
kb
iiii:~iii:~t:ii~{iii:::iii~:~"i~"iii~,i{iiiiii~iii!!ii~i4~iiii; ~';'~i:~ii#ii`iiii; -- 4.4 AM-11
,"~i
,.. ~ i , ~
"iii!~
l
.,L:Itt.l|lli, i~:":::::,;:;::. ::li!:~m::::z:: :::;~!:;:::ilili fihir ~ . ; i ~ i i i i i i - ; i ~ ! : : .: "iii;iiil!:ii~!~ii:~= "~:" " "i~iW :i ~ " :~i - -
AM - 13
~-'
'-'~
4
• 4
i
~i"i~*[ti:: g;u :: :~: z::;; ;i~ ,",':-",'iiii~!id.'i,':lii~iil ~dii ! ~ i i ii,i i ~ i ~ i ui:¢i:l=ltilili'.l~ifil.'~lil.~liullill~ii.'~t~ll
r ~ fi ~
AM -14
i
4.4
2,4 i~.:[~Liil]iiiiiiillii~iiii~Fi'u;iii|~ii~ii~iii'i!~i:;; t .r
;;il.":~iiii" ~ ;!i ";'~i!:'" ;
Fiqure 2. Northern blot analysis of poly(A)+RNA prepared from human brains. Lanes I-4, controls (90, 69, 78 and 57 years of age; diagnosed as multi-infarct dementia, Parkinson's disease, cerebral infarction and multiple sclerosis, in order); lanes 5-7, Alzheimer's disease patients (57, 69 and 87 years of age, in order). Four kinds of hybridization probes (Fig. I ) were used as indicated. No band was detected by AM-I 5 probe. 475
of
Vol. 157, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
8 - a c t i n b a n d (Fig. 2)
was
estimated,
and
the m e a n v a l u e s
c o m p a r e d b e t w e e n the Alzheimer's disease group and (Fig.
3).
was
mRNA
1.12 for A P P 6 9 5
probed by AM-13,
expression mRNA
levels
significant results,
mRNA
was
2.04,
tentatively
specifically
in
by S t u d e n t that
Alzheimer's
was
t-test.
APP770
for
statistically
B a s e d on t h e s e
mRNA
disease.
expression
This
conclusion
to be substantiated by analysis of more cases.
the e x p r e s s i o n
of A P P
mRNAs
in A l z h e i m e r ' s
there has been
a controversy
8-protein gene
in Alzheimer's disease was reported
who
APP mRNA
thereby
analysis cortex
been
proposed
not
(22).
neuronal
higher
in
subpopulations
in
overproduction however,
Rather,
Alzheimer's
of
has not
Northern
level of A P P m R N A
in situ
APP m R N A
by Delabar et al.
possible
(18-21).
the other hand,
the differential
of
disease,
Duplication of a m y l o i d
This idea,
the o v e r a l l
typically
suggested an increase of and
idea
by others
that
On
an brain.
supported
indicated
was
controls
among reports.
in the p a t i e n t ' s
necessarily
(23),
and 1.11
the ratio for APP770
and the difference
concluded
increased
As for
(17),
group
no r e m a r k a b l e change in the
By contrast,
at a l e v e l of p<0.05
we
p r o b e d by AM-11,
indicating
of these mRNAs.
probed by AM-14
remains
the control
The ratio of the m e a n value for Alzheimer's disease to that
for c o n t r o l APP751
were
blot
in c e r e b r a l
disease
than
hybridization
in
studies
in neurons of the nucleus basalis
APP m R N A
expression
Alzheimer's
disease
within
hippocampal
(24).
In
none
of
these reports were studied the expression patterns of various APP mRNA species.
Only Palmert
the APP m R N A
(25)
lacking insert(s)
the locus ceruleus b e t w e e n APP751
reported
elevation
of the
level of
in neurons of the nucleus basalis and
in Alzheimer's disease,
albeit with no distinction
m R N A and APP770 mRNA.
Our p r e l i m i n a r y BamHI-BglII
et al.
analysis
by
Northern blotting
fragment of APP695 cDNA (Fig.
476
I)
has
with
suggested
a shorter that the
Vol. 157, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
AM-11
>'
AM-13
AM-14
2.5
2.5
2.5
e6
2.0
2.0
2.0
mllm 7
1.5
1.5
r-o~ "o 1.5
*4
"6 *3 e4
~
1.0
o)
e5
lO
el m
0.5
*2 *3
el
el
0.5
e6
e4
0.5
0
I
I
0
CTL
CTL
A 0
I
0
A D
CTL
A D
Fiqure 3. Relative densities of autoradiograms of Northern blotting analysis for control (CTL) and Alzheimer's disease (AD) groups. The mean value of each CTL group is taken as unity. The numbers beside dots represent the case n u m b e r s for w h i c h the densities were calculated (Fig. 2). Bars indicate the m e a n values of relative densities in each group. * p<0.05, Student t-test.
total
amount
disease
of A P P
(unpublished
a significant change the
in A P P 6 9 5
overexpression for
of
of
of A l z h e i m e r ' s by e x o n
J
hypothesis inhibitor J,
with
APP770, of
APP
is n o t
J along
function
of
or w i t h o u t
to
remains
possible
sequence leading
(11,
is
exon
any to
that the I,
of k n o w n
fragment
26),
imposes
to a b e r r a n t
8-protein.
477
of
exon that
I
the
J) e n c o d e d
proteins, An
J affects
and
its
attractive the p r o t e a s e
the f l a n k i n g
by f r a g m e n t
at a t h r e o n i n e a conformational
metabolism
to
to p a t h o g e n e s i s
(fragment
clarified.
that
simply
possible
related
of
by a
suggests
ascribable
peptide
O-glycosylation
finding
expression
is
or t h a t
the
unaccompanied
it s e e m s
be
in A l z h e i m e r ' s
disease,
not
I
acid
to
with
expression
Rather,
with
fragment
together
aberrant
19 a m i n o
is
appreciably
in A l z h e i m e r ' s
homologous
activity
mRNA
inhibitor.
at this m o m e n t
thereby
result,
nor
The
change
8-protein
gene
disease.
the T h r - X - X - P r o
mRNA
amyloid
exon
physiological
This
or APP751 of
not
in A P P 7 7 0
a protease
coexpression
does
data).
increase
deposition
coding
mRNAs
residue
of
change
on
of A P P and d e p o s i t i o n
Vol. 157, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ACKNOWLEDGEMENTS We t h a n k Drs. M. Ogawa, T. Seko, K. Hara, R. M a t s u m o t o and T. Kimura for providing us with brain samples, and Dr. I. Saito and Mr. S. Horiguchi for useful discussion. The work was partly supported by Grants-in-Aid and Special Grant for Clinical Investigation from the Ministry of Education, Science and Culture, Japan.
REFERENCES I. 2. 3. 4. 5. 6. 7. 8. 9. I0. 11. 12. 13. 14. 15. 16. 17. 18.
19. 20. 21.
Mountjoy, C.Q., Tomlinson, B.E. and Gibson, P.H. (1982) J. Neurol. Sci. 57, 89-103. Glenner, G.G. and Wong, C.W. (I 984) Biochem. Biophys. Res. Commun. 120, 885-890. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. and B e y r e u t h e r , K. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249. Wong, C.W., Q u a r a n t a , V. and G l e n n e r , G.G. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 8 7 2 9 - 8 7 3 2 . Masters, C.L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R.N. and B e y r e u t h e r , K. (I 985) E M B O J. 4, 2757-2763. Kang, J., L e m a i r e , H.-G., U n t e r b e c k , A., S a l b a u m , J.M., M a s t e r s , C.L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K. and M~ller-Hill, B. (1987) Nature (London) 325, 733-736. Robakis, N.K., Ramakrishna, N., Wolfe, G. and Wisniewski, H.M. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 4190-4194. Goldgaber, D., Lerman, M . I . , McBride, O.W., Saffiotti, U. and Gajdusek, D.C. (I 987) Science 235, 877-880. Tanzi, R.E., Gusella, J.F., W a t k i n s , P.C., Bruns, G.A.P., St G e o r g e - H y s l o p , P., Van Keuren, M.L., P a t t e r s o n , D., Pagan, S.j Kurnit, D.M. and Neve, R.L. (1987) S c i e n c e 235, 880-884. Schubert, D., Schroeder, R., LaCorbiere, M., Saitoh, T. anc Cole, G. (I 988) S c i e n c e 241, 223-226. Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S. an(" Ito, H. (1988) N a t u r e (London) 331, 530-532. Ponte, P., Gonzalez-DeWhitt, P., Schilling, J., Miller, J. Hsu, D., G r e e n b e r g , B., Davis, K., W a l l a c e , W., L i e b e r b u r g , I. Fuller, F. and Cordell, B. (1988) Nature (London) 331, 525-527 Tanzi, R.E., M c C l a t c h e y , A.I., L a m p e r t i , E.D., V i l l a - K o m a r o f f , L., Gusella, J.F. and Neve, R.L. (I 988) N a t u r e (London) 331, 5 2 8 - 5 3 0 Chirgwin, J.M., Przybyla, A . E . , MacDonald, R.J. and Rutter W.J. (1979) Biochemistry 18, 5294-5299. Aviv, H. and Leder, P. (1972) Proc. Natl. Acad. Sci. U.S.A. 69 1408-1412. T h o m a s , P.S. (1980) Proc. Natl. Acad. Sci. U.S.A. 77, 5 2 0 1 - 5 2 0 5 Delabar, J.-M., G o l d g a b e r , D., L a m o u r , Y., Nicole, A., Huret J.-L., De Grouchy, J., B r o w n , P., G a j d u s e k , D.C. and Sinet, P.-~ (1987) Science 235, 1390-1392. St G e o r g e - H y s l o p , P.H., Tanzi, R.E., Polinsky, R.J., Neve, R . L Pollen, D., D r a c h m a n , D., G r o w d o n , J., Cupples, L.A., Nee, L Myers, R.H., O'Sullivan, D., W a t k i n s , P.C., Amos, J.A., Deutsc? C.K., B o d f i s h , J.W., K i n s b o u r n e , M., F e l d m a n , R.G., Bruni, A A m a d u c c i , L., Foncin, J.-F. and Gusella, J.F. (I 987) S c i e n c e 236 664-666. Tanzi, R.E., Bird, E.D., Latt, S.A. and Neve, R.L. (1987) Scien( 238, 666-669. P o d l i s n y , M.B., Lee, G. and Selkoe, D.J. (1987) S c i e n c e 238, 6 6 ¢ 671 . Furuya, H., Sasaki, H., Goto, I., Wong, C.W., Glenner, G.G. a] Sakaki, Y. (1988) Biochem. Biophys. Res. Commun. 150, 75-81. 478
Vol. 157, No. 2, 1988
22. 23. 24. 25. 26.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Zain, S.B., Salim, M., Chou, W . - G . , Sajdel-Sulkowska, E.M., Majocha, R.E. and Marotta, C.A. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 929-933. Cohen, M.L., Golde, T.E., Usiak, M.F., Younkin, L.H. and Younkin, S.G. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 1227-1231. Higgins, G.A., Lewis, D.A., B a h m a n y a r , S., Goldgaber, D., Gajdusek, D.C., Young, W.G., Morrison, J.H. and Wilson, M.C. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 1297-1301. Palmert, M.R., Golde, T.E., Cohen, M.L., Kovacs, D.M., Tanzi, R.E., Gusella, J.F., Usiak, M.F., Younkin, L.H. and Younkin, S.G. (1988) Science 241, 1080-1084. Suzuki, K., Kusumoto, H., Deyashiki, Y., Nishioka, J., M a r u y a m a , I., Zushi, M., Kawahara, S., Honda, G., Y a m a m o t o , S. and Horiguchi, S. (1987) E M B O J. 6, 1891-1897.
479